Literature DB >> 10832021

Intracerebroventricular infusion of nerve growth factor induces pain-like response in rats.

J Hao1, T Ebendal, X Xu, Z Wiesenfeld-Hallin, M Eriksdotter Jönhagen.   

Abstract

New strategies have recently been developed where infusion of neurotrophic factors into the brain can rescue different neuronal populations. However, negative side effects have been observed in clinical trials infusing nerve growth factor (NGF) into the lateral ventricle in man, namely pain. Little is known about pain behavior in animals after intracerebroventricular (i.c.v.) neurotrophic injections. Thus, we have examined the effects of i.c.v. infusion of NGF for 2 weeks on the behavioral response of rats to mechanical, cold and heat stimulation. Seven micrograms/day of NGF elicited a significant decrease in vocalization threshold to mechanical stimulation and a significantly increased response to cold and heat stimuli as compared with control. The concentration of NGF in cerebrospinal fluid (CSF) was significantly increased as compared with non-allodynic rats. The enhanced responses to mechanical and heat, but not to cold, stimulation were significantly reduced by CP-99994, a selective antagonist to tachykinin NK-1 receptors. When NGF was infused into the brain parenchyma (striatum, cortex and septum) no allodynic nor hyperalgesic responses could be detected. These results indicate that in rats i.c.v. but not intraparenchymal infusion of NGF induce mechanical and cold allodynia as well as heat hyperalgesia, which is mediated, at least in part, by activation of NK-1 receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832021     DOI: 10.1016/s0304-3940(00)01107-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Green tea polyphenols potentiate the action of nerve growth factor to induce neuritogenesis: possible role of reactive oxygen species.

Authors:  Usha Gundimeda; Thomas H McNeill; Jason E Schiffman; David R Hinton; Rayudu Gopalakrishna
Journal:  J Neurosci Res       Date:  2010-10-08       Impact factor: 4.164

3.  Tanezumab for the treatment of pain from osteoarthritis of the knee.

Authors:  Nancy E Lane; Thomas J Schnitzer; Charles A Birbara; Masoud Mokhtarani; David L Shelton; Mike D Smith; Mark T Brown
Journal:  N Engl J Med       Date:  2010-09-29       Impact factor: 91.245

4.  Evidence for the modulation of nociception in mice by central mast cells.

Authors:  C L Kissel; K J Kovács; A A Larson
Journal:  Eur J Pain       Date:  2017-07-19       Impact factor: 3.931

5.  Antihyperalgesic and anti-inflammatory effects of atorvastatin in chronic constriction injury-induced neuropathic pain in rats.

Authors:  Nitya N Pathak; Venkanna Balaganur; Madhu C Lingaraju; Amar S More; Vinay Kant; Dhirendra Kumar; Dinesh Kumar; Surendra Kumar Tandan
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

6.  Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.

Authors:  Helga Eyjolfsdottir; Maria Eriksdotter; Bengt Linderoth; Göran Lind; Bengt Juliusson; Philip Kusk; Ove Almkvist; Niels Andreasen; Kaj Blennow; Daniel Ferreira; Eric Westman; Inger Nennesmo; Azadeh Karami; Taher Darreh-Shori; Ahmadul Kadir; Agneta Nordberg; Erik Sundström; Lars-Olof Wahlund; Anders Wall; Maria Wiberg; Bengt Winblad; Åke Seiger; Lars Wahlberg; Per Almqvist
Journal:  Alzheimers Res Ther       Date:  2016-07-07       Impact factor: 6.982

7.  Constitutive activity of transient receptor potential vanilloid type 1 triggers spontaneous firing in nerve growth factor-treated dorsal root ganglion neurons of rats.

Authors:  Naoki Kitamura; Erika Nagami; Yumi Matsushita; Tomohiko Kayano; Izumi Shibuya
Journal:  IBRO Rep       Date:  2018-08-18

8.  The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid.

Authors:  Michael G Harrington; Alfred N Fonteh; Elena Oborina; Patricia Liao; Robert P Cowan; Gordon McComb; Jesus N Chavez; John Rush; Roger G Biringer; Andreas F Hühmer
Journal:  Cerebrospinal Fluid Res       Date:  2009-09-07

9.  PSA-NCAM positive neural progenitors stably expressing BDNF promote functional recovery in a mouse model of spinal cord injury.

Authors:  Jennifer Butenschön; Tina Zimmermann; Nikolai Schmarowski; Robert Nitsch; Barbara Fackelmeier; Kevin Friedemann; Konstantin Radyushkin; Jan Baumgart; Beat Lutz; Julia Leschik
Journal:  Stem Cell Res Ther       Date:  2016-01-13       Impact factor: 6.832

10.  Nerve growth factor inhibitor with novel-binding domain demonstrates nanomolar efficacy in both cell-based and cell-free assay systems.

Authors:  Allison E Kennedy; Corey A Laamanen; Mitchell S Ross; Rahul Vohra; Douglas R Boreham; John A Scott; Gregory M Ross
Journal:  Pharmacol Res Perspect       Date:  2017-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.